What You Should Know:
– Leo Cancer Care, a pioneer in radiotherapy treatment devices, has successfully raised $40M in funding round led by Catalio Capital Management.
– The investment, which also saw participation from new and…
Continue Reading
The current standard-of-care (SOC) practice for defining the clinical target volume (CTV) for radiation therapy (RT) in patients with glioblastoma still employs an isotropic 1–2 cm expansion of the T2-hyperintensity lesion, without considering the heterogeneous…
Continue Reading
For patients with locally advanced cervical cancer (LACC), precise survival prediction models could guide personalized treatment. We developed and validated CerviPro, a deep learning-based multimodal prognostic model, to predict disease-free survival (DFS) in 1018…
Continue Reading
This is a multi-institutional study to evaluate a head-and-neck CT auto-segmentation software across seven institutions globally. 11 lymph node levels and 7 organs-at-risk contours were evaluated in a two-phase study design. Time savings were…
Continue Reading
Accurate prediction of prognosis and postoperative radiotherapy response is critical for personalized treatment in head and neck squamous cell carcinoma (HNSCC). We developed a multimodal deep learning model (MDLM) integrating computed tomography, whole-slide images,…
Continue Reading
An advanced radiotherapy planning system has been rolled out at The Royal Marsden NHS Foundation Trust to enhance personalised treatment for patients.
RaySearch Laboratories’ technology introduces online adaptive radiotherapy (oART), which enables clinicians to adjust…
In tumor radiotherapy, monitoring patient body position is crucial for improving efficacy and reducing complications. We developed a contact-based body position monitoring system using pressure sensors and artificial intelligence, enabling non-invasive, radiation-free, real-time monitoring….
Continue Reading
NHS Shared Business Services (NHS SBS) is planning the formation of a new framework agreement for AI solutions in healthcare.
It will be named Healthcare Artificial Intelligence Solutions and will replace the frameworks for AI…
Researchers at The Clatterbridge Cancer Centre NHS Foundation Trust in Wirral are using AI to enhance the precision of radiotherapy for prostate cancer.
The PIVOTALboost study, which ran from 2018, recently closed after surveying data…
Groundbreaking Study Results
An international multicenter analysis has revealed remarkable outcomes for patients receiving CyberKnife radiosurgery (SRS) and fractionated stereotactic radiotherapy (FSRT) for brainstem metastases. The study, published in the International Journal of Cancer, demonstrates…
